Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, the ProShares UltraShort Health Care ETF (NYSEMKT: RXD ) has received the dreaded one-star ranking.
With that in mind, let's take a closer look at RXD and see what CAPS investors are saying about the ETF right now.
RXD facts
Inception | January 2007� |
Total Net Assets | $4.5 million |
Investment Approach | Seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. The index measures the performance of the health-care sector of the U.S. equity market. |
Expense Ratio | 0.95% |
1-Year / 3-Year / 5-Year Returns | (37.3%) / (29.7%) / (24.7%) |
Alternatives | ProShares UltraShort Dow30 (NYSEMKT: DXD ) |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 194 All-Star members who have rated RXD believe the ETF will underperform the S&P 500 going forward.
Just last month, one of those Fools, TerryHogan, succinctly summed up the RXD bear case for our community:
First of all [UltraShorts] are just plain crap for long-term holdings. Second, I like health care in the U.S. I think Boomers, Obamacare, and [obesity] ... will be good for the health care industry in the states for the next 20-30 years.
If you want market-thumping returns, you need to protect your portfolio from any undue risk. Luckily, our special report on ETFs highlights three funds that are poised to soar in the next recovery. It's 100% free, but won't last forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
No comments:
Post a Comment